Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Operating Leases (2019 - 2025)

Avanos Medical (AVNS) has disclosed Operating Leases for 7 consecutive years, with $20.4 million as the latest value for Q4 2025.

  • Quarterly Operating Leases fell 17.07% to $20.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.4 million through Dec 2025, down 17.07% year-over-year, with the annual reading at $20.4 million for FY2025, 17.07% down from the prior year.
  • Operating Leases hit $20.4 million in Q4 2025 for Avanos Medical, down from $21.4 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $57.5 million in Q4 2021 to a low of $20.4 million in Q4 2025.
  • Historically, Operating Leases has averaged $33.8 million across 5 years, with a median of $31.6 million in 2023.
  • Biggest five-year swings in Operating Leases: crashed 43.48% in 2022 and later increased 26.46% in 2023.
  • Year by year, Operating Leases stood at $57.5 million in 2021, then plummeted by 43.48% to $32.5 million in 2022, then rose by 26.46% to $41.1 million in 2023, then plummeted by 40.15% to $24.6 million in 2024, then fell by 17.07% to $20.4 million in 2025.
  • Business Quant data shows Operating Leases for AVNS at $20.4 million in Q4 2025, $21.4 million in Q3 2025, and $21.8 million in Q2 2025.